Hvis Vectibix anvendes under graviditet, eller hvis patienten bliver gravid, mens hun får dette lægemiddel, skal hun underrettes om den mulige risiko for afbrydelse af graviditeten og om potential faren for fosteret.
If Vectibix is used during pregnancy or if the patient becomes pregnant while receiving this medicinal product, she should be advised of the potential risk for loss of the pregnancy or potential hazard to the foetus.